[1]白旭东,唐志刚,王学斌.99Tcm标记异腈类配合物的研究进展[J].国际放射医学核医学杂志,2005,29(1):19-22.
　BAI Xu-dong,TANG Zhi-gang,WANG Xue-bin.The development of 99Tcm labeled isonitrile complexes[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):19-22.
点击复制

99Tcm标记异腈类配合物的研究进展(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第1期
页码:
19-22
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The development of 99Tcm labeled isonitrile complexes
作者:
白旭东;  唐志刚;  王学斌
100875 北京, 北京师范大学化学系放辐化研究室
Author(s):
BAI Xu-dong;  TANG Zhi-gang;  WANG Xue-bin
Department of Chemistry, Beijing Normal University, Beijing 100875, China
关键词:
锝; 异腈; 心肌; 肿瘤; 多药耐药
Keywords:
technetium; isonitrile; myocardium; tumor; multidrug resistance
分类号:
R817
摘要:
99Tcm标记的异腈类配合物是目前国内外应用最广泛的心肌灌注显像剂,在肿瘤的诊断方面也有重要应用。本文简要介绍了异腈配体合成及标记化合物的制备方法,并对99Tcm标记异腈类配合物的发展、分类及应用进展作了归纳总结。
Abstract:
Tcm labeled isonitrile complexes is the most widely used myocardial perfusion imaging agents, and it is also used to diagnose tumors. This review gives a sum up of the development, classifica-tion and application of 99Tcm labeled isonitrile complexes, and the synthesis methods of isonitrile ligands and labeled complexes are given.

参考文献/References:

1 Wackers FJT, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile:human biodistrilmtion,dosimetry, safety, and preliminary comparison[J]. J Nucl Med, 1989,30(3):301-311.
2 Zhang XZ, Wang XB, Jia F, et al. Preparation, characterization and biodistribution of a new technetium-99m nitrido complex with 2methoxyisobutylisonitrile and comparison with 99mTc-MIBI[J]. J Labelled cpd Radiopharm, 2002, 45(12):1029-1043.
3 Hao GY, Zhang JY, Liu BL, et al. Synthesis, separation and biodistribution of 99mTc-CO-MIBI complex[J]. J Labelled Cpd Radiopharm,2004, 47(8):513-521.
4 Zhang XZ, Wang XB, Tang ZG, et al. Effects d Tween-80 on the biodistrlbution of several lipophilic technetium-99m complexes[J].Nucl Med Biol, 2001, 28(3):303-308.
5 Pauwels EKJ, McCready VR, Stoot JHMB, et al. The mechanism of accumulation of tumour-localising radiopharmaceuticals[J]. Eur J Nucl Med, 1998, 25(3):277-305.
6 Sciuto R Pasqualoni R Bergomi S, et al. Prognostic value of 99mTc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy[J]. J Nucl Med 2002, 43(6):745-751.
7 Burak Z, Moretti JL, Ersoy O, et al. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug protein and P-glycoprotein expression[J]. J Nucl Med, 2003, 44(9):1394-1401.
8 Barbarics E, Kronauge iF, Jones AG, et al. Uptake of cationic technetium complexes in cultured human cacinoma cells and human xenografts[J]. Nucl Med Biol, 1998, 25(7):667-673.
9 Dyszlewski M, Blake HM, Dahlheimer JL, et al. Characterization of a novel 99mTc-carbonyl complex as a functional probe of MDRI P-glycoprotein transport activity[J]. Mol Imaging, 2002, 1(1):24-35.

相似文献/References:

[1]栾兆生,周雯,唐为国,等.99Tcm标记化合物显像检测冠心病的优化方案探讨[J].国际放射医学核医学杂志,2010,34(1):42.[doi:10.3760/cma.j.issn.1673-4114.2010.01.011]
　LUAN Zhao-sheng,ZHOU Wen,TANG Wei-guo,et al.The optimal program of 99Tcm labeled radionuclide imaging in diagnosing coronary disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):42.[doi:10.3760/cma.j.issn.1673-4114.2010.01.011]
[2]刘键,张现忠,张仕坚,等.99Tcm标记双膦酸盐骨显像剂的研究进展[J].国际放射医学核医学杂志,2009,33(5):296.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.013]
　LIU Jian,ZHA NG Xian-zhong,ZHA NG Shi-jian,et al.The new advanced of 99Tcm-labeled bisphosphonates as bone scintigraphy agent[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(1):296.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.013]
[3]徐萍,刘强,李锐.99mTc-明胶的制备和生物学分布研究[J].国际放射医学核医学杂志,2008,32(1):19.
[4]薛艳,安瑞芳,喻明启,等.99mTc标记抗β-人绒毛膜促性腺激素单克隆抗体[J].国际放射医学核医学杂志,2007,31(2):68.
　XUE Yan,AN Rui-fang,YU Ming-qi,et al.Direct labeling of anti β-human chorionic gonadotropin monoclonal antibody with 99mTc[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):68.
[5]范光磊,吴翼伟,章斌.用99mTc标记胰岛素样生长因子1类似物的方法学研究[J].国际放射医学核医学杂志,2007,31(4):208.
　FAN Guang-lei,WU Yi-wei,ZHANG Bin.Investigations of labeling insulin-like growth factor 1 analogue with 99mTc[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):208.
[6]胡旋,李锐.放射性微球技术测定脊髓血流量的实验观察[J].国际放射医学核医学杂志,2007,31(4):215.
　HU Xuan,LI Rui.Experimental study of capacity of the blood blow of spinal cord using radiolabelling microspbere technique[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):215.
[7]陈坤山.在锝极有限情况下如何充分利用锝进行骨显像[J].国际放射医学核医学杂志,2007,31(4):239.
[8]戴光复,金月英,田源,等.冰冻切片放射自显影技术在微剂量研究中的应用[J].国际放射医学核医学杂志,2006,30(5):264.
　DAI Guang-fu,JIN Yue-ying,TIAN Yuan,et al.Application of study in microdosimetry with the frozen sectioning microaut-oradiogtraphy technique[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):264.
[9]王佳琼,王自正,姚薇萱,等.乳腺肿瘤生长抑素受体表达与生长抑素受体显像[J].国际放射医学核医学杂志,2006,30(1):17.
　WANG Jia-qiong,WANG Zi-zheng,YAO Wei-xuan,et al.Somatostatin receptor scintigraphy and somatostatin receptors expression in breast neoplasm[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):17.
[10]兰晓莉.两种99Tcm标记双功能螯合剂:NHS-MAG3和HYNIC[J].国际放射医学核医学杂志,2005,29(1):15.
　LAN Xiao-li.Two bifunctional chelating agents used in 99Tcm labeling: NHS-MAG3 and HYNIC[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):15.

备注/Memo

备注/Memo:
收稿日期:2004-12-02。
更新日期/Last Update: 1900-01-01